The resignation of head drug regulator George Tidmarsh comes amid concerns about conduct related to the lupus nephritis drug ...

The drama continued Monday with senior FDA leaders as more details emerged about former Center for Drug Evaluation and ...

The administration, as well as HHS, publicly praised Marty Makary’s leadership despite persistent upheaval at the agency.

It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...

Dr. George Tidmarsh, the FDA drug regulator who was placed on leave and complained of a “toxic” work environment in an ...

Dr. George Tidmarsh, who joined the FDA in July, stepped down Sunday, The New York Times reported. His resignation came just ...

Less than 24 hours after resigning his post as the FDA’s head drug regulator, George Tidmarsh is reportedly reconsidering his decision and vowing to fight for his name and credibility amid a probe ...

A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...

A federal spokesperson said Dr. George Tidmarsh left the agency after federal lawyers began looking into “serious concerns ...

Aurinia Pharmaceuticals (AUPH) stock gains as the company's Q3 2025 results beat forecasts despite an FDA information request ...

George Tidmarsh has resigned as director of the US Food and Drug Administration’s Center for Drug Evaluation and Research ...